This event is put on by the PMPRB NPDUIS
As part of the National Prescription Drug Utilization Information System (NPDUIS) research initiative, the Patented Medicine Prices Review Board has just released the seventh edition of CompassRx, a series that monitors and analyzes the cost pressures driving changes in prescription drug expenditures in Canadian public drug plans. This edition provides insight into the factors driving the growth in drug and dispensing costs in 2020/21, as well as a retrospective review of recent trends in public plan costs and utilization.
English and French information sessions will be offered on Wednesday, February 8 and Thursday, February 9 through GoToWebinar. We recommend using the Google Chrome web browser for the best user experience. Questions can be posed during the presentation using the GoToWebinar chat function and will be answered by email following the session.